Aida Pharmaceuticals Inc is a company principally engaged in the development, production and distribution of pharmaceutical products. Through its subsidiaries, the Company has nine production lines for the manufacture of antibiotics, cardiovascular and anti-tumor drugs in various forms, including injectable powder, injectable liquid, capsules, tablets and ointments.

Employees

Sector

Pharmaceuticals

More about the company

Market Closed - OTC Markets 14:56:03 2025-12-10 EST			5-day change	1st Jan Change
0.000200 ^USD	-.--%		-33.55%	-33.55%

Current month	-33.55%
1 month	-33.55%

Market Cap	4.05M 3.6M 3.36M 3.07M 5.76M 390M 5.85M 40.68M 15.76M 199M 15.2M 14.87M 639M	P/E 2006	32.1x	P/E 2007	11.1x
Enterprise Value	19.57M 17.4M 16.26M 14.83M 27.83M 1.88B 28.25M 197M 76.15M 961M 73.47M 71.87M 3.09B	EV / Sales 2006	2.42x	EV / Sales 2007	1.58x
Free-Float	57.04%	Yield 2006 *	-	Yield 2007	-

-1-11-29	Aida Pharmaceutics : Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing	PR
-1-11-29	Aida Pharmaceutics : Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition	PR
-1-11-29	Aida Pharmaceutics : Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website	PR
-1-11-29	Aida Pharmaceutics : Aida Announces New Anti-Cancer Drug Under Development	PR
-1-11-29	Aida Pharmaceutics : Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development	PR

1 week	-33.55%
Current month	-33.55%
1 month	-33.55%
3 months	-33.55%
6 months	-33.55%
Current year	-33.55%

Aida Pharmaceuticals, Inc. Stock

Stocks

AIDA

US0087211027

Pharmaceuticals

Valuation: Aida Pharmaceuticals, Inc.

Chart: Aida Pharmaceuticals, Inc.

Press Releases: Aida Pharmaceuticals, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Aida Pharmaceuticals, Inc.

Generic Pharmaceuticals

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AIDA PHARMACEUTICALS, INC.	-.--%	-33.55%	-.--%	+100.00%	8.13K
ELI LILLY AND COMPANY	-0.62%	-0.10%	+50.70%	+114.07%	1,031B
JOHNSON & JOHNSON	-2.30%	-3.90%	+39.50%	+66.07%	638B
ABBVIE INC.	-0.63%	-1.94%	+12.26%	+74.38%	462B
MERCK & CO., INC.	-1.03%	-2.88%	+71.35%	+39.69%	359B
ROCHE HOLDING AG	-0.03%	-3.91%	+34.28%	+39.35%	335B
NOVARTIS AG	-1.58%	+0.39%	+17.92%	+25.77%	273B
ASTRAZENECA PLC	-2.02%	-3.20%	+7.60%	+8.38%	253B
AMGEN INC.	-3.38%	+0.29%	+44.32%	+51.54%	228B
GILEAD SCIENCES, INC.	-1.04%	-2.56%	+32.88%	+96.82%	185B
Average	-0.51%	-0.33%	+31.08%	+61.61%	376.39B
Weighted average by Cap.	-0.14%	-0.35%	+38.05%	+69.18%

	2006	2007
Net sales	29.64M 26.36M 24.63M 22.46M 42.16M 2.85B 42.79M 298M 115M 1.46B 111M 109M 4.68B	29.2M 25.97M 24.26M 22.13M 41.54M 2.81B 42.16M 293M 114M 1.43B 110M 107M 4.61B
Net income	1.45M 1.29M 1.21M 1.1M 2.07M 140M 2.1M 14.6M 5.66M 71.36M 5.46M 5.34M 229M	2.74M 2.44M 2.28M 2.08M 3.9M 264M 3.95M 27.52M 10.66M 135M 10.29M 10.06M 433M
Net Debt	23.1M 20.54M 19.19M 17.51M 32.86M 2.22B 33.35M 232M 89.9M 1.13B 86.73M 84.84M 3.65B	15.52M 13.8M 12.89M 11.76M 22.07M 1.49B 22.4M 156M 60.39M 762M 58.26M 56.99M 2.45B

1 year	0		0
3 years	0		0
5 years	0		0.01
10 years	0		0.18